Indinavir

123 interactions 10 explained in plain English
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Dihydroergotamine Injection Finerenone Ivabradine Colchicine Lovastatin Lurasidone
14 Contraindicated 85 Major 24 Moderate
All (123) Contraindicated (14) Major (85) Moderate (24)

Contraindicated

Indinavir Colchicine Colcrys Explained Increased colchicine exposure and an increased risk of fatal toxicity Details Indinavir Simvastatin Flolipid Explained Increased simvastatin exposure and an increased risk of myopathy or rhabdomyolysis Details Indinavir Alfuzosin UroXatral Increased alfuzosin plasma concentrations Details Indinavir Dihydroergotamine Injection DHE-45® Injection Increased ergot derivative exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Indinavir Dihydroergotamine Nasal Spray Migranal Increased ergot derivative exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Indinavir Finerenone Kerendia Increased finerenone exposure and an increased risk of finerenone-related adverse effects Details Indinavir Ivabradine Corlanor Increased ivabradine exposure and an increased risk of ivabradine-related adverse effects [like bradycardia and conduction disturb... Details Indinavir Lovastatin Altocor® Increased lovastatin exposure and an increased risk of myopathy or rhabdomyolysis Details Indinavir Lurasidone Latuda Increased lurasidone exposure Details Indinavir Methylergonovine Methergine Increased ergot derivative exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Indinavir Midazolam Nasal Spray Nayzilam Increased midazolam plasma concentrations Details Indinavir Midazolam Injection Nayzilam Increased midazolam plasma concentrations Details Indinavir Naloxegol Movantik Increased naloxegol exposure and an increased risk of naloxegol-related adverse effects Details Indinavir Nimodipine Nimotop Increased plasma concentrations of nimodipine Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.